Iran Flirts With Chemical and Bio Warheads as Netanyahu Meets Trump.
Iran’s Islamic Revolutionary Guard Corps (IRGC) is quietly probing one of the most dangerous escalation paths yet: the possible integration of chemical and biological payloads into its long-range ballistic missile program, according to a report by Iran International citing military sources.
The report claims the IRGC has intensified internal inquiries in recent months, driven by rising regional tensions and Tehran’s fear of another direct clash with Israel and the United States. Missile launchers have reportedly been shifted toward eastern Iran, a move analysts read as part of broader strategic dispersal.
Israeli and Western sources caution that Iran is not yet producing chemical or biological warheads. Still, even exploratory steps are raising alarms. These early-stage inquiries suggest Tehran is testing options beyond nuclear escalation—especially after suffering setbacks to its nuclear program earlier this year.
The timing is telling. The revelations surfaced just as Prime Minister Benjamin Netanyahu meets U.S. President Donald Trump, where Israel is pushing Washington to refocus on Iran’s ballistic missile threat, not just its nuclear ambitions. Chemical and biological weapons—cheaper, easier to obtain, and politically explosive—could be Tehran’s way of forcing that conversation.
History adds weight to the concern. Syria, far weaker than Iran, once stockpiled and used chemical weapons during its civil war. Iraq threatened chemical Scud attacks on Israel during the 1991 Gulf War. For years, Israel distributed gas masks to its population in anticipation of such scenarios.
Yet deterrence still matters. None of Israel’s enemies have used chemical or biological weapons against it—largely due to fear of devastating retaliation. Israeli sources believe Iran understands that crossing this line could trigger a response far more destructive than any tactical gain.
Strategically, the calculus is murky. Analysts note Iran could cause more damage by firing hundreds of conventional ballistic missiles than by attempting to deploy chemical or biological payloads, which are unreliable and difficult to control.
Still, the signal is clear: Iran is searching for new pressure points. Even without concrete deployment, the mere exploration of chemical and biological options marks a dangerous shift—one aimed less at battlefield advantage and more at reshaping deterrence, diplomacy, and Washington’s attention.
The message heading into Netanyahu’s talks with Trump is unmistakable: Iran’s threat spectrum is widening, and missiles—not just nukes—are back at the center of the strategic equation.
